Core Scientific (CORZW) Equity Average (2021 - 2025)
Core Scientific (CORZW) has disclosed Equity Average for 5 consecutive years, with -$1.1 billion as the latest value for Q4 2025.
- Quarterly Equity Average fell 25.18% to -$1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 billion through Dec 2025, down 25.18% year-over-year, with the annual reading at -$952.9 million for FY2025, 23.75% down from the prior year.
- Equity Average hit -$1.1 billion in Q4 2025 for Core Scientific, up from -$1.2 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.2 billion in Q1 2022 to a low of -$1.2 billion in Q3 2025.
- Historically, Equity Average has averaged -$278.8 million across 5 years, with a median of -$404.5 million in 2023.
- Biggest five-year swings in Equity Average: skyrocketed 1224.13% in 2022 and later tumbled 265.72% in 2023.
- Year by year, Equity Average stood at $645.1 million in 2021, then plummeted by 126.07% to -$168.2 million in 2022, then crashed by 202.0% to -$507.8 million in 2023, then crashed by 74.24% to -$884.9 million in 2024, then dropped by 25.18% to -$1.1 billion in 2025.
- Business Quant data shows Equity Average for CORZW at -$1.1 billion in Q4 2025, -$1.2 billion in Q3 2025, and -$750.4 million in Q2 2025.